OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Clinical characteristics, outcome, and risk factors for early and late intrahepatic recurrence of female patients after curative resection of hepatocellular carcinoma
Tao Li, Lun‐Xiu Qin, Xiao Gong, et al.
Surgery (2014) Vol. 156, Iss. 3, pp. 651-660
Closed Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

CT-based radiomics signature: a potential biomarker for preoperative prediction of early recurrence in hepatocellular carcinoma
Ying Zhou, Lan He, Yanqi Huang, et al.
Abdominal Radiology (2017) Vol. 42, Iss. 6, pp. 1695-1704
Closed Access | Times Cited: 203

Gender Differences in the Pathogenesis and Risk Factors of Hepatocellular Carcinoma
Riccardo Nevola, Giovanni Tortorella, Valerio Rosato, et al.
Biology (2023) Vol. 12, Iss. 7, pp. 984-984
Open Access | Times Cited: 46

Sex Hormone-Dependent Physiology and Diseases of Liver
Paulina Kur, Agnieszka Kolasa, Kamila Misiakiewicz-Has, et al.
International Journal of Environmental Research and Public Health (2020) Vol. 17, Iss. 8, pp. 2620-2620
Open Access | Times Cited: 130

Gender disparity in hepatocellular carcinoma (HCC): multiple underlying mechanisms
Bo Zheng, Yanjing Zhu, Hongyang Wang, et al.
Science China Life Sciences (2017) Vol. 60, Iss. 6, pp. 575-584
Closed Access | Times Cited: 100

Clinical Features of Recurrence After Hepatic Resection for Early-Stage Hepatocellular Carcinoma and Long-Term Survival Outcomes of Patients with Recurrence: A Multi-institutional Analysis
Lan‐Qing Yao, Zhengliang Chen, Zihan Feng, et al.
Annals of Surgical Oncology (2022) Vol. 29, Iss. 7, pp. 4291-4303
Closed Access | Times Cited: 56

Immunosenescence and immunotherapy in elderly patients with hepatocellular carcinoma
Dengyong Zhang, Yan Zhu, Zhengchao Shen, et al.
Seminars in Cancer Biology (2025) Vol. 111, pp. 60-75
Closed Access | Times Cited: 1

Risk Factors for Early Recurrence of Single Lesion Hepatocellular Carcinoma After Curative Resection
Mitsugi Shimoda, Kazuma Tago, Takayuki Shiraki, et al.
World Journal of Surgery (2016) Vol. 40, Iss. 10, pp. 2466-2471
Closed Access | Times Cited: 48

Predictors and long-term prognosis of early and late recurrence for patients undergoing hepatic resection of hepatocellular carcinoma: a large-scale multicenter study
Wentao Yan, Chao Li, Lan‐Qing Yao, et al.
HepatoBiliary Surgery and Nutrition (2021) Vol. 12, Iss. 2, pp. 155-168
Open Access | Times Cited: 34

Gender disparity in hepatocellular carcinoma recurrence after curative hepatectomy
Tianyi Liang, Yongfei He, Shutian Mo, et al.
Annals of Hepatology (2022) Vol. 27, Iss. 3, pp. 100695-100695
Open Access | Times Cited: 26

Preoperative inflammation-based markers predict early and late recurrence of hepatocellular carcinoma after curative hepatectomy
Yue Liu, Zhong‐Xia Wang, Yin Cao, et al.
Hepatobiliary & pancreatic diseases international (2016) Vol. 15, Iss. 3, pp. 266-274
Closed Access | Times Cited: 43

Up-regulation of fibroblast growth factor 19 and its receptor associates with progression from fatty liver to hepatocellular carcinoma
Yan Li, Weizhong Zhang, Anne Doughtie, et al.
Oncotarget (2016) Vol. 7, Iss. 32, pp. 52329-52339
Open Access | Times Cited: 41

Sex difference in recurrence and survival after liver resection for hepatocellular carcinoma: A multicenter study
Han Zhang, Jun Han, Hao Xing, et al.
Surgery (2018) Vol. 165, Iss. 3, pp. 516-524
Closed Access | Times Cited: 37

Can IVIM help predict HCC recurrence after hepatectomy?
Yao Zhang, Sichi Kuang, Qungang Shan, et al.
European Radiology (2019) Vol. 29, Iss. 11, pp. 5791-5803
Closed Access | Times Cited: 32

Positive HBcAb is associated with higher risk of early recurrence and poorer survival after curative resection of HBV‐related HCC
Tao Li, Shu‐Kang Wang, Jian Zhou, et al.
Liver International (2015) Vol. 36, Iss. 2, pp. 284-292
Closed Access | Times Cited: 28

Prognostic Significance of Preoperative Serum Alpha-fetoprotein in Hepatocellular Carcinoma and Correlation with Clinicopathological Factors: a Single-center Experience from China
Songlin An, Ting Xiao, Liming Wang, et al.
Asian Pacific Journal of Cancer Prevention (2015) Vol. 16, Iss. 10, pp. 4421-4427
Open Access | Times Cited: 25

RECK expression is associated with angiogenesis and immunogenic Tumor Microenvironment in Hepatocellular Carcinoma, and is a prognostic factor for better survival
Zhao‐Ru Dong, Zhi‐Qiang Chen, Xiaoyun Yang, et al.
Journal of Cancer (2021) Vol. 12, Iss. 13, pp. 3827-3840
Open Access | Times Cited: 12

The effect of age, sex, and eastern cooperative oncology group performance status on the efficacy and safety of immune checkpoint inhibitors in patients with hepatocellular carcinoma: a systematic review and meta-analysis
Cheng‐Long Han, Bao‐Wen Tian, Lun‐Jie Yan, et al.
Expert Review of Anticancer Therapy (2024) Vol. 24, Iss. 5, pp. 303-312
Closed Access | Times Cited: 1

Nuclear PKM2 expression, an independent risk factor for ER after curative resection of hepatocellular carcinoma
Fangtian Fan, Hongyan Wu, Zhaoguo Liu, et al.
Biomedicine & Pharmacotherapy (2016) Vol. 84, pp. 1858-1864
Closed Access | Times Cited: 9

Page 1 - Next Page

Scroll to top